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Drug misuse has significant impacts on families and
communities and is a major concern for Australia. The
misuse of licit drugs (such as alcohol and tobacco) continues
to have the most significant negative impacts, but the use of
illicit drugs is also a contributing factor in ill-health, injuries,
violence and criminal behaviour, workplace problems and
the disruption of family, community and the broader society
[1]. For categories and definitions of illicit drugs: view http://
www.healthinfonet.ecu.edu.au/illicit_review/info
The greater level of substance misuse in the Indigenous
population reflects the history of dispossession and
oppression of Indigenous people; their entrenched social
and economic marginalisation requires holistic and
well-funded strategies to address the underlying social
determinants of Indigenous ill-health [2].

General aspects of illicit drug
use in Australia
M o r b i d i t y a n d m o r ta l i t y
The use of illicit drugs by Indigenous people needs to be seen in
the overall context of illicit drug use in Australia (for the extent
of illicit drug use in Australia see appendix 1). Illicit drug use
accounts for significant morbidity and mortality. There were 8,389
hospital separations in Australia in 2005-06 for which the principal
diagnosis was in relation to the four major illicit drug types
(opioids, amphetamines, cannabis, and cocaine) [3]. For the period
1993-2006, separations were highest for opioids across the entire

This review– or an updated version
can be viewed at:
http://www.healthinfonet.ecu.edu.au/illicits_review

period, followed by amphetamines, cannabis and cocaine [4].
In 2005, there were a total of 410 deaths in which opioids (n=374),
methamphetamines (n=26) and cocaine (n=10) were determined
to be the underlying cause of death among those aged 15-54 years
[5, 6]. Opioid deaths are not necessarily due to heroin; for example,
in Tasmania and the Northern Territory deaths are more likely to
be related to pharmaceutical opioids [7]. Methamphetamine
and cocaine were mentioned in a further 42 and 5 ‘drug-induced’
deaths respectively [6].
In 2003, illicit drug use accounted for 2% of the total burden of
disease in Australia [8].

T h e c o st of dru g u se
The health and economic cost of drug use in Australia is significant.
Collins and Lapsley (2008) estimated the total social cost (burden
of disease) of drug use in Australia in 2004-05 to be $56.1 billion,
of which $8.1 billion (15%) related to the cost of illicit drug use. In
real terms, this represents an increase of 11.3% in the annual total
social cost of illicit drug use in Australia from $6.1 billion in 199899 (representing $7.3 billion in 2004-05 figures) to $8.1 billion in
2004-05 [9].
In 2002-03, a total of $3.2 billion was spent by governments
in relation to illicit drugs; law enforcement-related activity
accounted for 75% of spending, and prevention, treatment, and
harm reduction accounted for 10%, 7%, and 1% respectively [10].
Proactive spending (the direct actions of government in relation to
drug policy), accounted for 42% ($1.3 billion) of total government
expenditure; law enforcement-related activity accounted for more
than half of proactive spending (56%), prevention, treatment, and
harm reduction accounted for 23%, 17%, and 3% respectively [10].
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The extent of illicit drug use among Indigenous people
Evidence of illicit drug use among Indigenous people – population surveys
According to recent population surveys (2004-2005 National
Aboriginal and Torres Strait Islander Health Survey (NATSIHS); 2007
National Drug Strategy Household Survey (NDSHS)) the overall
level of illicit drug use in the previous 12 months among the
Indigenous population aged 15 years or older living in non-remote
areas (28%) was more than twice the level of the general Australian
population aged 14 years or older (13%) (Figure 1) [11, 12]. The
higher level of drug use applied across all drug types.
For both the Indigenous population and the general Australian
population cannabis was the most commonly used illicit drug.
For the Indigenous population, cannabis was followed by
amphetamines, analgesics (painkillers) and then ecstasy; in the
general Australian population cannabis was followed by ecstasy,
analgesics and then amphetamines [11, 12].
The overall level of illicit drug use in the previous 12 months by
Indigenous people aged 15 years or older living in non-remote
areas was 4.7% higher in 2004-2005 than in 2002 (Figure 2) [11].
This change reflects a 20% increase in the number of Indigenous
people using illicit drugs in this 2-3 year period. The increase in
cannabis use (18%) was around the same as the overall increase,
but the increases in amphetamine and ecstasy use were much
greater (46% and 137% respectively) [11]. For information on
sources and limitations of information on illicit drug use among
Indigenous people see appendix 2.

2
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P o ly d ru g u s e

Use of an illicit drug does not occur in isolation and is often
associated with other health-risk factors. According to the 20042005 NATSIHS, 12% of Indigenous males and 7% of Indigenous
females had used three or more illicit substances in the previous
12 months [11].
Generally, Indigenous people who had used illicit drugs in the
previous 12 months were more likely than those who had never used
illicit drugs to smoke (66% compared with 34%) and to consume
alcohol at risky or high risk levels (28% compared with 13%) [15].

Evidence from other sources

Age of first use
Data relating to the age of Indigenous people when they first use
drugs is based mostly on small surveys (Cannabis: Gray et al, 1997;
Dance et al, 2004; Clough et al, 2004. Injecting drug use: Larson, 1996;
Shoobridge et al, 1998). It indicates that the mean age of first use
for illicit drugs is up to 6 years younger than the national average:
12-17 years for cannabis (18 years non-Indigenous) and 17-18 years
for injecting drug use (21 years non-Indigenous) [12, 16].

http://www.healthinfonet.ecu.edu.au/illicits_review
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Cannabis use in remote communities

Polydrug use

The use of cannabis by Indigenous people in remote communities
in Arnhem Land has increased dramatically over the past 20 years or
so [17]. Cannabis use was not detected in the ‘Top End’ communities
in the mid 1980s, but the most recent research found 67% of males
and 22% of females aged 13-36 years were currently using cannabis;
these figures represent cannabis use among males more than twice
that reported in the late 1990s for males aged over 15 years (31%)
and cannabis use among females nearly three times that reported in
the late 1990s for females aged over 15 years (8%).

Cannabis and other drugs

In comparison with figures from the 2004-2005 NATSIHS, this equates
to cannabis use among Indigenous males in remote communities
more than twice that of their non-remote counterparts (28%), and
cannabis use among Indigenous females in remote communities
nearly one third higher than their non-remote counterparts (17%) [13].

Illicit drug use other than cannabis

Proportions of illicit drug use in the previous 12 months for the
Indigenous and general Australian populations, by drug type,
Australia, selected years
Indigenous

Illicit drug use

Cannabis

Amphetamines

The Arnhem Land studies also found that petrol sniffers and those
who used amphetamines were all cannabis users [17].
H e r o i n , a mp h e t a m i n e s a n d o t h e r d r u g s

Emerging evidence supports a preference among Indigenous
injecting drug users for amphetamines over heroin; this is most likely
a reflection of the longer lasting euphoric effects of amphetamine
and its economic affordability in comparison to heroin [18]. With
evidence that amphetamine use is increasing among Indigenous
people there are fears that non-Indigenous suppliers will use the
existing, largely Indigenous, cannabis networks in rural and remote
communities for the flow of amphetamines [19].

Figure 1.

The studies of remote Indigenous populations in Arnhem Land
found that tobacco smokers were more likely than non-smokers
to use cannabis and that the likelihood increased as the quantity
of cannabis used increased [20]. Cannabis users, who also smoked
tobacco, reported smoking tobacco more heavily than non-users of
cannabis (although tobacco use had been taken up more recently
among cannabis users) [17]. For lifetime users of both tobacco and
cannabis, one-third had initiated the use of both substances at the
same time [20]. These findings suggest that for those who use both
tobacco and cannabis it is likely that their use is heavy in relation to
both drugs, with significant impacts on morbidity and mortality.

A 2001 study of over 300 Indigenous people in South Australia
who injected drugs (the largest single study of its type in Australia)
found that most people were polydrug users, using about four
different drugs within a six-month period. The most common
variations were heroin, speed, cannabis, alcohol and tobacco.
The drugs most often used in the previous 6 months were heroin
(97%), speed (68%), alcohol (66%), cannabis (63%), tobacco (55%),
benzodiazepines (34%) and methadone (34%) [21].

Figure 2.		Changes in proportions of Indigenous people using illicit drugs,
by drug type, Australia, 2002 and 2004-2005

2002 NATSISS

General Australian Population

Analgesics

Ecstasy

Illicit drug use

Cannabis

Amphetamines

Sources: 2004-2005 NATSIHS [13]; 2007 NDSHS [12]

Sources: 2002 NATSISS [14]; 2004-2005 NATSIHS [13]

Note:

Note:

3

Proportions are for: (1) Indigenous people aged 15 years or older living
in non-remote areas; and (2) general Australian population aged 14
years or older

Copyright © 2010 Australian Indigenous HealthInfoNet

2004-2005 NATSIHS

Analgesics

Ecstasy

Proportions are for Indigenous people aged 15 years or older living in
non-remote areas
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Impact of Indigenous illicit drug use
H e a lt h i mpa c t s

Deaths and hospitalisation
National data on mortality among Indigenous people are not available
[22], but data collated by the Health Department of Western Australia
found that the deaths of 26 Indigenous males and 14 Indigenous
females in 1990-99 had been attributed to the use of drugs other
than alcohol or tobacco (age-standardised rates were 11.1 and 5.9 per
100,000 population respectively) [23]. These death rates are similar
to those for the total Australian population in 1999: 14 per 100,000
population for males and 5 per 100,000 for females [24].
The only detailed information about hospitalisation as a result
of illicit drug use was compiled as a part of reporting against the
Aboriginal and Torres Strait Islander health performance framework
[11]. Hospitalisation rates for drug-related causes were generally
higher for Indigenous people than for non-Indigenous people
living in Queensland, Western Australia, South Australia and the

Table 1.

Northern Territory in July 2002 to June 2004 (comprising about
60% of the total Indigenous population), particularly for mental/
behavioural disorders relating to use of cannabinoids and multiple
drugs and psychoactive substances (Table 1).
The trend of increasing prevalence of illicit drug misuse among
Indigenous people is reflected in studies by Patterson et al. (1999)
and Gray et al. (2001) of increases in morbidity for drugs other than
alcohol and tobacco in Western Australia between 1980 and 1995
and 1994 and 2000. Significant increases in admissions for illicit
drug use problems and increases in Hepatitis C notification rates
and hospital admission rates for conditions related to illicit drug
use were reported [23].

Hepatitis C and HIV/AIDS
A large proportion of Indigenous users of amphetamines and
opiates inject their drugs, with a high level of users sharing needles
[2]. Findings from the South Australian study on Indigenous

Hospitalisation related to drug use, by Indigenous status and cause, Queensland, WA, SA and the NT, July 2002 to June 2004

Cause of hospitalisation

Indigenous

Non-Indigenous

Number

Rate

Rate

Rate ratio

Psychotropic drugs, including antidepressants

258

0.4

0.4

1.1

Narcotics, including opium, heroin, methadone and

78

0.1

0.1

1.3

Antidepressants and barbiturates

220

0.4

0.3

1.5

Narcotics (includes cannabis, cocaine, heroin, opium

80

0.1

0.1

1.5

From use of cannabinoids

284

0.4

0.1

4.8

From use of multiple drugs and psychoactive

269

0.4

0.1

3.0

From use of other stimulants

226

0.4

0.2

2.0

From use of opioids

60

0.1

0.1

0.9

From use of sedatives

15

-

0.1

0.5

Poisoning

cocaine

Accidental poisoning

and methadone) and hallucinogens

Mental/behavioural disorders

substances

Source: AIHW, 2007 [11]

Notes:
		
		

4

1	Some of the causes of hospitalisation include non-illicit use of drugs
2	Rates are admissions per 1,000 population
3	Rate ratios are the Indigenous rates divided by the non-Indigenous rates prior to rounding of rates for presentation
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injecting drug users found that the people who regularly shared
needles (12% of the surveyed participants) were more likely
to be dependent, heavy polydrug users and frequent users of
amphetamines [21]. These findings have implications for the
spread of blood-borne viruses such as hepatitis C and HIV/AIDS.
Although poor reporting systems make it difficult to determine
the rate of viral infection among Indigenous drug users [2], the
‘HIV/AIDS, viral hepatitis and sexually transmissible infections
in Australia, Annual Surveillance Report 2007’ found that in the
most recent five-year period (2002-2006), the rate of hepatitis C
diagnosis increased in both the Indigenous and non-Indigenous
population in the Northern Territory (in contrast with a decreasing
trend nationally), but was lower in the Indigenous population. The
rate of newly diagnosed hepatitis C infection in the Indigenous
population of Western Australia and South Australia was between
two and three times, and five and 10 times higher respectively
than that in the non-Indigenous population [25]. This is likely to
be a significant underestimation given that as recently as 2005
Indigenous status was not recorded for 65% of new hepatitis C
notifications [2].
Similarly, despite the similarity in HIV infection rates between
Indigenous and non-Indigenous Australians, Indigenous
Australians are more likely than non-Indigenous Australians to
contract HIV infection through the use of shared needles. In the
most recent five-year period (2002-2006), the ‘HIV/AIDS, viral
hepatitis and sexually transmissible infections in Australia, Annual
Surveillance Report 2007’ reveals a three-fold increase in the
proportion of HIV infections attributed to injecting drug use among
Indigenous Australians since the 2000 report (18% compared with
6%), while the non-Indigenous rate has remained unchanged at
3% [25, 26].

Overdose
The National Drug and Alcohol Research Centre (NDARC), in their
report ‘Findings from the Illicit Drug Reporting System’ (IDRS),
found that 56% of participants using heroin and other opioids in
2007 had overdosed at some point in their lifetime. For participants
who used amphetamines, 6% reported overdosing at some point
in their lifetime [7]. In 2005, 46% of injecting drug users surveyed in
Australia had overdosed at some point in their lifetime [8].

5
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In 2001, a Western Australian study of 74 Indigenous people who
inject drugs found that 24% of participants had overdosed at some
time [27]. The authors note that these findings contrast with the
findings of Larson (1996), where 52% of Indigenous heroin users
had personally experienced overdose, however the lower overdose
rate in the Western Australian study was attributed to a lesser use of
heroin [27]. In 2001, a South Australian study of Indigenous injecting
drug users found that 21% had overdosed after injecting, and, in
contrast to the Western Australian study, 97% of participants had
used heroin in the previous six months [21]. These figures suggest
the overdose rate for Indigenous injecting drug users is variable;
being less than or equal to that of the general Australian injecting
drug user population. The concern for Indigenous injecting drug
users relates to the stigma and shame of injecting drug use and
the associated increased risks of overdose when injecting alone to
conceal drug use from family and friends [28].

Social and emotional wellbeing
The 2002 NATSISS found that Indigenous people experience
stressors in their lives at a rate one and a half times that of the
non-Indigenous population [14]. The most common stressors
reported in the 2004-05 NATSIHS were the death of a family
member or close friend (42%), serious illness or disability (28%),
alcohol and other drug related problems (20%), family member in
jail (19%), and inability to get work (17%) [15]. Indigenous people
are also hospitalised for mental disorders at twice the rate of other
Australians, with the greatest excess of mental health-related
hospitalisations in the younger adult age groups and the greatest
excess of mortality in the 35-54 year age group [1].
Findings from hospital data and mental health service providers
suggest Indigenous people have significantly more mental health
disorders associated with illicit drug misuse than non-Indigenous
Australians. The National Hospital Morbidity Database found that
Indigenous Australians were hospitalised for mental/behavioural
disorders from use of cannabinoids and from use of multiple
drug and psychoactive substances at a rate 5 times and 3 times
respectively that of non-Indigenous Australians [11]. Similarly,
Indigenous people presenting to public mental health services
were nearly 3 times more likely to have a principal diagnosis of
disorders due to psychoactive substance use than non-Indigenous
Australians (8% compared with 3%) [29].

http://www.healthinfonet.ecu.edu.au/illicits_review
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Co-morbidity
Co-morbidity is the co-occurrence of more than one disease or
disorder in an individual. It is known that mental health problems
co-occur with drug use problems and that both may influence each
other. Co-morbidity of substance use disorders with psychosis,
anxiety, affective, personality and other substance use disorders is
widespread and treatment outcomes are often poor [30].
The National Survey of the Mental Health and Wellbeing of
Adults (SMHWB) conducted in Australia in 1997 provided
information on the prevalence of mental disorders, including
anxiety, affective and substance use disorders among the
Australian population. Although a significant survey, and the
first of its kind, it did not cover people in remote areas and the
number of Aboriginal and Torres Strait Islander people who took
part in the survey was too small to provide reliable estimates of
their mental health [31, 32].
The SMHWB found significant rates of comorbidity among the
general Australian population. Of those with a substance use
disorder, 31% also had another mental disorder [32]. Although there
are no comprehensive studies of co-morbidity among Indigenous
people it is likely that the rates of co-morbidity are higher than
those of the general population [2].

Suicide
Over the last decade the Indigenous suicide rate has grown
compared with that of non-Indigenous people [15]. For the period
2001-2005, the Indigenous suicide rate was 3 and 4 times higher
for males (0-24 years and 25-34 years respectively) and 5 times
higher for females (0-24 years) compared with the corresponding
age-specific rates for non-Indigenous males and females. Between
1997 and 2000 the Indigenous suicide rate was 1.8 times higher
for males and 1.3 times higher for females than for their nonIndigenous counterparts [16].
Whereas alcohol remains the drug most associated with suicidal
ideation, various studies have shown that intoxication from drugs
other than alcohol also facilitates the suicide decision: Clough
and colleagues (2006) found a slight increase in the incidence of
self-harm (including suicide attempts) among cannabis users;
Shoobridge and colleagues (1998) found that more than half of
injectors had attempted suicide at least twice, and just over 90% of

6
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those attempting suicide were intoxicated at the time [16]. In the
Northern Territory there has been an 800% increase in Indigenous
suicide over the period 1981 – 2002. Those most at risk are
Indigenous males aged 45 years and under. In 2000-2002 misuse of
drugs other than alcohol was identified in 16% of cases [33].

Impa c t o n fa m i l i e s

Relationships
The impact of drug use on families is significant. In an Adelaide
study of Indigenous injecting drug users in 2001, half of those
interviewed cited family breakdown as a result of injecting drug
use [21]. Similarly, in a Western Australian study in 2001, users were
overwhelmingly more concerned about the impact of their drug
use on family and close relationships (60%) than the impact on
their own health (9%) [27]. Relationships suffer on many levels, and
a constant tension relates to sourcing money for substance use
[19].

Violence
Family violence was a recurring concern of community members in
remote areas; the heavy use of cannabis was believed to compound
the violence arising from the use of alcohol, kava or inhalant misuse
[19]. The majority of police in remote areas (76%) also believed
cannabis use contributed to domestic/family violence.
The increasing levels of amphetamine use (especially among those
with a predisposition for violence) is also likely to increase the
levels of violence in communities already experiencing high levels
of violence [18].
Whereas illicit drug users are often associated with the perpetration
of violence, Indigenous Australians who used at least one illicit
drug in the previous 12 months were more than twice as likely to
have been a victim of physical or threatened violence compared
with those who did not use illicit drugs (41% compared with 18%)
[29].

Child harm
In remote areas, communities expressed concern for child neglect
and the sexual exploitation of young people in relation to drug use
[19]. This concern was echoed by police who associated cannabis
use with disruption to schooling and with children trading sexual
favours for money or drugs.

http://www.healthinfonet.ecu.edu.au/illicits_review
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The influence of parental illicit drug use on children was highlighted
in a West Australian survey which found that children of parents
who used drugs other than alcohol or tobacco were more than
twice as likely to use marijuana than children whose parents did
not use illicit drugs (24% compared with 11%), were more likely
to both smoke and to use marijuana and were more likely to drink
alcohol and to drink to excess than those children whose parents
did not use illicit drugs [34].

C r i m e a n d i n c a r c e r at i o n
Indigenous people are incarcerated at highly disproportionate
rates compared with the non-Indigenous population. Data from
the National Prisoner Census showed that at 30 June 2007, 6,630
prisoners were Indigenous – an increase of 9% on 2006 numbers
and representing 24% of the total prisoner population (unchanged
from 2006). Using age-standardised rates, Indigenous people
were 13 times more likely to be in prison than non-Indigenous
people (also unchanged from 30 June 2006); in Western Australia
Indigenous people were 21 times more likely to be in prison than
non-Indigenous people - the highest Indigenous to non-Indigenous
rates of imprisonment in Australia [35].
In 2005, data from the Australian Institute of Criminology (AIC)
Drug Use Monitoring in Australia (DUMA) survey (carried out
in Queensland, New South Wales, South Australia and Western
Australia), which collects information on illicit drug use from
recently arrested detainees, found that positive drug tests were
returned for a higher proportion of Indigenous detainees than nonIndigenous detainees in all seven of the police stations surveyed;
the proportion returning positive drug tests ranged from 62% and
85% for Indigenous detainees compared with 47% and 73% for nonIndigenous detainees. For both Indigenous and non-Indigenous
detainees who tested positive to drugs, cannabis was the most
common drug and benzodiazepines and methamphetamine were
also common [11].

Review of illicit drug use among Indigenous peoples

have shown that the more common forms of criminal activities
carried out by Indigenous drug users are stealing, break and entry,
vandalism, gambling, dealing and violent crime such as assault. [16].
Supporting this, data from the National Prisoner Census showed
that at 30 June 2007, acts intended to cause injury and unlawful
entry with intent accounted for over 43% (2,204) of imprisonment
for Indigenous prisoners [35].

Economic costs
In remote communities it is likely that substance users spend a
significant proportion of their income on cannabis alone: up to a
third of their weekly median income of $160/week for those aged
13-36 and representing 6-10% of the total monetary resources in
these communities [17]. While much of this money remains in the
community, it places significant strain on the users themselves
and their families. In a South Australian study in 2001, Indigenous
injecting drug users experienced significant financial problems
[21]. The average weekly expenditure on injectable drugs among
Indigenous users ranged from $50 to $2100, with the median cost
per ‘taste’ being $75. This spending occurred within the context of
a median average income of $350 per week [16].
The high costs associated with funding illicit drug dependence account,
at least in part, for the increased rate of involvement in crime [36].

Examination of the 2002 NATSISS found that the two most
important factors relating to Indigenous prosecution and
imprisonment were high-risk alcohol consumption and illicit drug
use [36]. Use of certain drugs is, to some degree, associated with
specific criminal activities: cannabis and inhalant use is associated
with property damage, intravenous drug use is associated with
sex work, and alcohol is associated with violence. Various studies

7
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Factors contributing to illicit drug use among Indigenous people
Historical context of
I n d i g e n o u s d i s a d va n ta g e a n d
i l l ic i t dru g u se
A political economy perspective of Indigenous disadvantage
views political and economic factors as broadly determinative
of the more microbiological, psychological and social/cultural
factors that influence the behaviour of individuals and groups
[37]. Indigenous people experience significant disadvantage
across all socioeconomic indicators, including income, education,
employment and housing conditions [29]. Gray and colleagues
(2007) illustrate that the root of this disadvantage lies in the
dispossession and oppression of Indigenous people since the
arrival of the British in 1788 [2]. The British claimed Australia on
the grounds of terra nullius (a legal term meaning the land was
unoccupied and belonged to no one) despite the fact that an
estimated 750,000 people lived in Australia, with ancestry dating
back more than 60,000 years. Around the turn of the twentieth
century ‘social Darwinism’ (which held that less technologically
complex societies would give way to more technologically
complex societies) was used to justify the continued dispossession
of Indigenous people. It was considered that Indigenous people
would die out, a belief that was actively assisted through the
establishment of poorly resourced missions and government
settlements which closely regulated every aspect of Indigenous
lives. In this environment children of mixed descent were taken
from their parents and their culture ‘for their own good’. Indigenous
people were denied access to mainstream society; education was
denied and employment was limited to the most basic and menial
roles. Such overt discrimination continued through until the
implementation of policies of assimilation from the 1950s, but it
was not until 1962 that Indigenous people were able to vote and
it was not until 1967 that the Commonwealth could pass laws in
relation to Indigenous people.
The period of assimilation denied Indigenous people their culture
and gave way to policies of self-determination in the 1970s, but this
era ended in non-Indigenous declarations of failure and a return
to more assimilationist policies in the beginning of the twenty
first century [2]. Within this political economy context the social
determinants of health weigh heavily on Indigenous people.

S o c i a l d e t e r m i n a n t s o f h e a lt h

Education
Education is a critical pathway to employment opportunities
and associated increased living standards. In 2007, the Australian
Bureau of Statistics and Australian Institute of Health and Welfare

8
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(2008) reported that the retention rates for Indigenous people in
years 10, 11 and 12 were around 10%, 20% and 30% less respectively
than the non-Indigenous retention rates for those years. In 2006,
Indigenous people aged 15 years and over were half as likely as
non-Indigenous people to have completed school to year 12 (23%
compared with 49%) and twice as likely to have left school at year
9 or below (34% compared with 16%). Indigenous people living
in rural areas and remote areas were less likely to have completed
year 12 than their urban counterparts (22% and 14% respectively
compared with 31%). [15]. Lowell and colleagues (2003), found
that Indigenous people from rural and remote communities in
the Northern Territory believe that the loss of cultural knowledge
has contributed to the poor health status of their people and that
better health is not dependent on improved Western education,
but rather cultural education related to health issues, cultural
systems and knowledge [cited in 38]. Schwab (2006) provides
support for these beliefs, suggesting that the quality and cultural
appropriateness of education are important factors in determining
the influence of education on health outcomes for Indigenous
people [cited in 38].
Various studies have explored the link between educational
outcomes and substance use: a study of two remote communities
in Arnhem Land found that current cannabis users were less likely
to participate in education or training [17]; in an Adelaide study
of injecting drug users the average age of leaving school was 15
years [21]; and a study by Gray and colleagues (1997), showed that
children aged 8-17 disaffected from school were 23 times more
likely to be ‘polydrug users’[23].

Employment
As with education, the relationship between employment and
drug use is circular. An environment of underemployment or
unemployment is more likely to sustain drug use, and established
drug use is more likely to inhibit the ability or desire to work [16].
In 2006, one-third (33%) of Indigenous young people (aged 18-24
years) were fully engaged in work or study; less than half the rate
of non-Indigenous young people (71%). In remote areas, less than
one-fifth (18%) of Indigenous young people (aged 18-24 years)
were fully engaged in work or study [15].
The low rates of engagement in work or study for Indigenous
people compared with non-Indigenous people can be related
to the higher rate of drug use in the previous 12 months for
Indigenous people aged 15 years or over compared with nonIndigenous people aged 14 years and over (28% compared with
13%) [11, 12]. For Indigenous people in remote areas the lower rate
of engagement in work or study compared with Indigenous people
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in non-remote areas reflects an even greater rate of illicit drug use:
in remote communities, 67% of males and 22% of females aged
13 years and over currently used cannabis compared with 28% of
males and 18% of females aged 15 years and over in non-remote
areas [11, 17]. These figures represent an inverse relationship
between active engagement in work or study and drug use.
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(27% or 102,300 people) were living in overcrowded conditions;
23% of Indigenous households had 5 or more people resident, and
in Indigenous or mainstream community housing (representing
55% of the housing tenure in remote areas) an average of 4.8
people are resident per household [15].

Similarly, low employment rates were characteristic of injectors
in an Adelaide study in 2001 where two-thirds were unemployed
and only 3% had stable employment. [21]. Polydrug use may also
be more common among the unemployed: most injectors in the
Adelaide study cited above were polydrug users and unemployed
youth aged 15-17 were 13.5 times more likely to be ‘frequent
polydrug users’ [23].

No specific studies have investigated the relationship between
overcrowding and illicit drug use, but it seems likely that rates of
illicit drug use would also be higher. The Northern Territory’s Select
Committee on Substance Abuse in Communities (2007) found that
levels of stress attributable to overcrowding resulted in greater
harms from substance abuse and recommended that the highest
priority be given to alternatives to current approaches to housing
in remote communities [40].

Income

Fa m i ly a n d s o c i a l fa c t o r s

Studies show a clear and consistent relationship between individual
level of income and level of morbidity and mortality, with the
highest rates of morbidity and mortality experienced by those
on the lowest income [22]. In 2006, the median equivalised gross
household income of Indigenous Australians was equal to 56% that
of non-Indigenous Australians ($362 compared with $642) [15].

Family functioning and resilience are protective factors just as
family stressors (grief, domestic violence, ‘absent’ parents) are risk
factors. Family stressors are commonplace in communities where
substance use is problematic [16].

The relationship between income and health status has been
contested at the population level for Western industrialised
countries where an association between income and life
expectancy has not been found. Attention has therefore focused
on the contextual effects of inequality; the way in which factors
such as social status rather than income per se influence health
status. For Indigenous Australians the experience of ‘long-term
social exclusion and material marginalisation’ is manifest in their
much lower life expectancy [22]. How low income and low social
status impact on illicit drug use relates to the association between
social determinants such as unemployment, homelessness and
poverty and behaviours that damage health - including illicit
drug use; some have found the association is strongest between
deprivation and licit and illicit drug use, but evidence suggests
that this association is mediated by risk and protective factors
[22]. Importantly, Indigenous poverty cannot be viewed directly
through the lens of mainstream social determinant models of
health without also considering the complex interplay between
the ‘social, political and economic consequences of being an
Indigenous person in Australia’ [39].

Inducement by friends, or peer pressure, is a major influence in the
initiation of drug taking. Among the general Australian population
peer pressure was the second most common factor for first use (54%)
after curiosity (77%) [41]. The influence of the peer group is likely to
be stronger among those for whom home life is stressful [16].
In communities where drug use is not problematic it has been
found that meaningful activity (and not necessarily paid work) is a
protective factor. So too, recreational activities including sport and
cultural activities are considered a crucial primary intervention,
particularly in those areas where there is little structured social
activity [16].

Housing
Overcrowding is associated with adverse health outcomes,
including higher rates of smoking and drinking at hazardous levels
[15]. In 2006, around one-quarter of the Indigenous population
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Policies and strategies addressing illicit drug use among Indigenous people
N at i o n a l S t r at e g i c F r a m e w o r k
f or A b or ig i na l a n d Tor r e s
S t r a i t I s l a n d e r H e a lt h 2 0 0 3 - 2 0 1 3
( NSFATSIH )
The NSFATSIH is historically based in the articulation of the health
aspirations of Indigenous Australians as set out in the National
Aboriginal Health Strategy (1989) [42]. The NSFATSIH aims to
direct government action using a coordinated, collaborative and
multi-sectoral approach [43]. Social and emotional wellbeing is
a priority area of the framework which recognises the impact of
alcohol and other drug misuse on the health and wellbeing of
Indigenous people. The NSFATSIH supports the aims and activities
of the National Drug Strategy Aboriginal and Torres Strait Islander
Peoples’ Complementary Action Plan [43].

T h e N at i o n a l D r u g S t r at e g y
The National Drug Strategy (developed by the Ministerial Council
on Drug Strategy (MCDS)) is an umbrella framework which seeks to
reduce the harmful effects of drugs and drug use through a series
of national action plans addressing tobacco, alcohol, school-based
drug education and illicit drugs [44].

Harm minimisation
Since 1985 Australia’s drug strategy has embraced the principle of
harm minimisation to reduce drug-related harm. Harm minimisation
refers to the policies and strategies of supply reduction, demand
reduction and harm reduction which seek to reduce drug-related
harm by improving the health, social, and economic outcomes for
both the individual and the community [44].
Supply reduction strategies seek to reduce the production and
supply of illicit drugs and to control and regulate licit drugs [45].
Demand reduction strategies seek to reduce demand for substances
and include strategies aimed at preventing the uptake of harmful
drug use as well as strategies aimed at reducing drug use [45]
Harm reduction strategies seek to reduce drug-related harm for individuals
and communities while not necessarily reducing drug use [45]
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Funding
In 2002-03, proactive spending (the direct actions of government
in relation to drug policy), accounted for 42% ($1.3 billion) of total
government expenditure in relation to illicit drugs ($3.2 billion);
law enforcement-related activity accounted for more than half
of proactive spending (56%), prevention, treatment and harm
reduction accounted for 23%, 17%, and 3% respectively [10].

N at i o n a l D r u g S t r at e g y
A b or ig i na l a n d Tor r e s
Strait Islander Peoples’
C o mp l e m e n ta r y A c t i o n P l a n
2003-2009
The Aboriginal and Torres Strait Islander Complementary Action
Plan was developed in recognition of the particular challenges
Indigenous people are faced with in reducing the harm arising from
substance use and provides national direction for the reduction
of harm, complementing all other existing national action plans
under the National Drug Strategy Framework [44].

Roles and responsibilities
The Aboriginal and Torres Strait Islander Peoples’ complementary
action plan stresses the need for a whole-of-system response
based on effective partnerships across levels of government, across
portfolios, with Aboriginal and Torres Strait Islander communitycontrolled organisations, and with the communities themselves to
ensure the best use of available resources in minimising the harms
arising from substance use [46].

Key result areas
The following six key result areas shape the action plan [16]:
•

building individual, family and community capacity to address
current and future issues in the use of alcohol, tobacco and
other drugs, and promote their own health and wellbeing

•

actively promoting a whole-of-government commitment,
alongside collaboration with community-controlled services and
non-governmental organisations, in reducing drug-related harm
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for Aboriginal and Torres Strait Islander populations in meeting
the mainstream performance indicators specified by the
substance-specific national action plans

•

improving access to the appropriate range of health and
wellbeing services that play a role in addressing alcohol,
tobacco and other drug issues

•

recognising the role of holistic approaches from prevention
through to treatment and continuing care that is locally
available and accessible

•

the number of regional health plans developed under the
partnership agreements that incorporate ATOD strategies
listed in the complementary action plan

•

introducing and improving workforce initiatives to enhanced
capacity of community-controlled and mainstream
organisations to provide quality data

•

•

increasing ownership and sustainable partnerships for research,
monitoring, evaluation and dissemination of information

evidence that all appropriate workforce, research, and
evaluation and monitoring actions that arise from funding for
the substance-specific action plans are developed in line with
the intentions of the complementary action plan to improve
capacity and to promote holistic models of intervention

Performance indicators
The National Illicit Drug Action Plan performance indicators are as
follows [46]:
•

prevalence of use in the previous 12 months in the general
population and by young people under 25 years of age

•

perception that it is all right to use drugs regularly (at least
monthly)

•

purity and price of illicit drugs

•

number of community-based episodes of care

•

number of people diverted to treatment from the police

•

participation in treatment by Aboriginal and Torres Strait
Islander peoples’, and people from culturally and linguistically
diverse backgrounds

•

number of people receiving methadone treatment at mid-year
census

•

number of fatal overdoses

•

incidence of HIV diagnoses attributable to injecting drug use

•

illicit drug use among arrestees

Specific national indicators for the National Aboriginal and Torres
Strait Islander Complementary Action Plan 2003-2006 are [46]:
•
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Services
Services provided to Indigenous people for substance misuse can be
conceptualised using the harm minimisation framework of Australia’s
National Drug Strategy. This framework uses demand reduction,
harm reduction and supply control strategies (explained above) in a
tripartite approach to interventions to reduce substance misuse [47].
The interventions under this tripartite approach can be categorised
as primary, secondary or tertiary [47]. Primary interventions are
those which seek to prevent the uptake of substance use in the
first place; secondary interventions are those which address the
needs of the user and the problems associated with that use for
the individual and the community; tertiary interventions are those
which address the treatment and rehabilitation of chronic users as
well as the interventions required for those impaired as a result of
their use [16].

Demand reduction

Primary interventions
Primary intervention includes strategies addressing the broader
social determinants of health as well as health sector specific
strategies focussing on education and information on the risks
associated with drug use [47].
S o c ia l d e t e r m i na n t s o f h e a lt h

It is widely acknowledged that interventions need to address the
social determinants of health that propel Indigenous Australians
into drug use [16]. The most essential determinant being education,
and particularly secondary education and youth training whereby
meaningful employment and recreation are requisite for stemming
the tide of boredom, frustration and directionless experienced by
so many young Indigenous people.
R e c r e at i o n

The introduction of recreational activities is especially important in
regional and remote settings where few opportunities for recreational
activity exist. d’Abbs and McLean (2000) found that success is more
likely if a wide range of activities are provided encompassing a greater
range of interests inclusive of gender relevant interests [16]. Likewise,
the Northern Territory’s Select Committee on Substance Abuse in the
Community (2007) found that the provision of recreational activities is
a major element of demand reduction and the key to guiding young
people away from substance misuse and therefore recommended
recreation facilities be accorded due significance in funding priorities
by government [40].
E d u c at i o n / i n f o r m at i o n o n d ru g u s e

Gray and colleagues (2004) describe a range of culturally specific drug
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use education interventions; health promotion projects including
theatre which reflects local and regional circumstances, advertising
through regional Indigenous television, and promotional materials
developed by Aboriginal community controlled health services
(ACCHSs) using local people on posters and pamphlets. State
and territory health departments have also produced culturally
appropriate and relevant health promotion materials [47].
The Australian Government funded Aboriginal and Torres Strait
Islander Primary Health Care Services, Service Activity Reporting 200304 Key Results (SAR) found that all services provided‘health promotion/
education’ but as this is not broken down into specific areas it is not
possible to determine what percentage of interventions applied
to substance use health promotion [48]. Less than 5% of Australian
Government funded Aboriginal and Torres Strait Islander Substance
Use Specific Services provided community-based education and
prevention programs [49]. Australian Government funded alcohol and
other drug treatment services in Australia provided information and
education to 11% of Indigenous clients [50].
Screening

In 2004-2005, 20% of Indigenous people had seen a general
practitioner in the previous two weeks and 17% had seen an
Aboriginal Health Worker in the previous two weeks [13]. Primary
health care settings, therefore, provide an ideal opportunity
to identify substance use through programs such as ‘Ferret’; a
program widely used in ACCHSs which prompts staff to ask about
alcohol and tobacco consumption as part of annual health checks
[47].

Secondary and tertiary interventions
Secondary interventions include ‘brief intervention’; the advice
given by health practitioners on reducing or giving up substance
use. Tertiary interventions include treatment, rehabilitation and
counselling of chronic drug users [47].
Br i e f i n t e rv e n t ion s

Brief intervention describes strategies including screening,
brief advice, referral to specialist support, counselling and brief
motivational interviewing [51]. In a study to determine the
feasibility and acceptability of providing brief intervention in an
urban Indigenous health setting, brief intervention was found
to be ‘culturally appropriate, but barriers to wider administration
included lack of time and the complexity of patients’ presenting
health problems’ [51, p. 375]. It was also found that the research
raised awareness of the utility of brief intervention for substance
use in primary health care settings.
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The use of primary health care services by Indigenous people (as
cited above) provides the ideal opportunity for ‘brief intervention’
for those for whom substance use has become problematic [47].
T h e I l l i c i t D ru g D i v e r s i o n I n i t iat i v e
( IDDI ) i n r u r a l a n d r e m o t e A u s t r a l i a

The IDDI is an initiative of the Council of Australian Governments
(COAG) which sought early intervention in the prevention of a new
generation of drug users. The strategy involves diverting offenders
who have had little prior contact with the justice system for drug
offences, and/or whose apprehension involves a small quantity of
illicit drugs, into appropriate drug treatment services. Diversion
can occur via the police or the courts [52].
As at June 2006, 22 of the 32 IDDI-funded programs were
operating in rural and remote areas. The IDDI has been responsible
for increasing the pathways to drug assessment, education and
treatment through the police and court diversion programs as
well as increasing the number of locations where alcohol and
drug workers operate. The IDDI has also served to increase the
involvement of service providers in the assessment, education and
treatment of people diverted under the program in 231 rural and
remote locations [52].
The IDDI has limited quantitative data about the outcomes
of those who have attended diversion programs. In 2005-06,
compliance rates indicated that completion for police diversion
programs ranged from 56% to 95%, while completion for court
diversion programs ranged from 29% to 100%. The extent of
positive outcomes for clients (aside from completion rates) cannot
be determined due to insufficient evidence, although many service
providers believe diversion provides a valuable opportunity to
access this important client group [52].
T h e A l c o h o l a n d o t h e r d ru g t r e at m e n t
s e rv i c e s i n Au s t r a l ia 2 0 0 6 - 0 7 – R e p o rt o n t h e
N a t i o n a l M i n i m u m D a ta S e t ( AODTS - N M DS )

The AODTS-NMDS includes Australian Government funded agencies
(government and non-government) providing alcohol and/or
other drug treatment services. Services which do not fall within
the scope of the AODTS-NMDS include Aboriginal and Torres Strait
Islander substance use specific services and health care services,
treatment services based in prisons, agencies providing overnight
stays such as ‘sobering-up shelters’ and health promotion services
such as needle and syringe exchange programs [50].
A closed treatment episode is defined as a period of contact
having defined dates of commencement and cessation between
an agency and a client. In 2006-07, Indigenous clients comprised
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one in ten closed treatment episodes (10%), unchanged from the
previous three reporting periods [50].
Treatment episodes among the 10-19 years age group were
more common for Indigenous clients than for non-Indigenous
clients (18% compared with 11%); for those aged over 40,
Indigenous clients were less common than non-Indigenous
clients. These differences may relate to the younger age structure
of the Indigenous population compared with the non-Indigenous
population [50].
Indigenous clients reported the same drugs of concern as the total
population - alcohol, cannabis, opioids and amphetamines; alcohol
was more likely to be nominated by Indigenous clients (49%
compared with 42%) and opioids were less likely to be nominated
by Indigenous clients (11% compared with 15%).
The main treatment types involving Indigenous clients were
counselling (38%), assessment (18%), withdrawal management
(detoxification) (12%), and information and education (11%).
Indigenous clients were less likely to receive withdrawal
management than non-Indigenous clients (12% compared with
17%), and more likely to receive information and education only,
and assessment only, than non-Indigenous clients (11% and 18%
compared with 9% and 14%) [50].
Ab original and Torres Strait Islander
s u b s ta n c e u s e s p e c i f i c s e rv i c e s

In 2005-06, 37 out of 40 Australian Government funded Aboriginal
and Torres Strait Islander substance use specific services (which
comprised 27 residential and 13 non-residential services)
responded to the Drug and Alcohol Services Report (DASR) [49].
An episode of care is defined as contact between a client and a
staff member and, in contrast to the AODTS-NMDS, any change in
treatment or drug of concern does not constitute a new episode of
care [50]. Residential episodes of care begin at admission and end
at discharge [49]. In the case of ‘other care’ (non-residential care),
higher estimates of activity will be recorded as this relates to the
number of visits or phone calls between the service and clients.
Clients are counted only once regardless of how many times they
access assistance during the reporting year [49].
In 2005-06, 28,200 clients were seen by DASR services, of which
21,400 were Indigenous (76%). Approximately 1,900 Indigenous
clients received residential care involving 3,700 episodes of care.
Approximately 13,000 Indigenous clients received non-residential
care involving 49,200 episodes of care [49].
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The principal drugs of concern treated by DASR were alcohol,
cannabis, amphetamines, tobacco and benzodiazepines [49]. This
differs from the AODTS-NMDS which includes opioids in the top
four drugs of concern.
The most common methods of providing care reported by DASR
services included transport (100%), counselling (97%) and referral
services (97%). The most frequently used substance use treatment
approach by DASR services was abstinence (43%) [49]. These
findings cannot be compared with the AODTS-NMDS because they
relate to the services provided and approaches used by the services
rather than the numbers of clients receiving those services.
Ab original and Torres Strait Islander
P r i m a ry H e a lt h C a r e S e rv i c e s

In 2003-04, 139 of 140 Australian Government funded Aboriginal and
Torres Strait Islander primary health care services responded to the
Service Activity Reporting (SAR), of which, 138 provided usable data [48].
An episode of care is defined as contact between a client and health
service staff for the provision of health care. Approximately 88% of
health care episodes were provided to Aboriginal and Torres Strait
Islander clients.
At least one substance use program targeting cannabis was offered
by around 50% of services and up to 25% of services offered
programs for illicit drugs other than cannabis; principally opiates,
benzodiazepines and amphetamines. Programs addressing
multiple drug use were offered by 30% of services. More generally,
substance use issues are covered on an individual client basis as
they arise in the course of client care [48].

Ha r m r e du c t ion

Secondary intervention
Loxley and colleagues (2004) noted the programs with the strongest
evidential support for harm reduction were: needle and syringe
distribution to reduce the spread of blood-borne viruses; the use of
methadone for opiate dependence to reduce the risk of overdose
and blood-borne viruses; and hepatitis B vaccinations [22].
In 2005-06, the DASR found that 27% of services used harm
reduction interventions (such as information about safe using
practices) in relation to substance use, and approximately 1,170
Indigenous clients received sobering up/residential respite
involving 5,220 episodes of care [49]. In terms of injecting drug
users, in 2003-04, 30 ACCHSs (22%) operated needle exchange
programs [2].

B a r r i e r s t o t r e at m e n t
Barriers to treatment for Indigenous people relate to the availability
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of services, the accessibility of services, the cultural appropriateness
of services, the range of treatment options and the cost of services.

Availability of services
Remoteness

The Australian Institute of Health and Welfare (2006) has
acknowledged the barrier of geography in providing intervention
services in remote communities [16]. Multi-function police facilities
in remote areas of Western Australia (in which police share remote
facilities with staff from the health, education and welfare sectors
in an attempt to adequately respond to family violence and child
abuse) may provide an opportunity to incorporate substance
misuse services (to date, nine remote areas have been prioritised
for multi-function police facilities) [53].
I d e n t i f i c at i o n o f s e rv i c e n e e d s

The Northern Territory’s Select Committee on Substance Abuse in the
Community (2007) found that there was a lack of consultation with
communities to ascertain their needs and resources and recommended
a ‘community audit’ to ensure program provision is prioritised for
individual communities [40]. Similarly, Teasdale and colleagues (2008)
in their study assessing acceptability and accessibility of mainstream
services for Indigenous Australians in a Sydney Area Health Service
found that there was a lack of identification of the drug and alcohol
needs of people living in the service area [54].

Accessibility of services
In 2005-06, all of the Australian Government funded Aboriginal
and Torres Strait Islander substance use specific services who
responded to the DASR (37 out of 40 services) provided transport
services to clients [49]. This finding highlights the role the provision
of transport services play in the accessibility of services. Similarly,
where clients are not provided with transport to services there is a
need for outreach services; Teasdale and colleagues (2008) identified
a lack of outreach services for Indigenous clients needing to access
mainstream services in a Sydney Area Health Service. Additionally,
a narrow timeframe to access opioid pharmacotherapy was also
identified as a barrier to accessibility [54].

Culturally appropriate services
The Australian Institute of Health and Welfare (2006) has highlighted
the continuing need to ensure the cultural appropriateness of
services. Services need to be more Indigenous ‘specific’, ‘friendly
and accessible’, and ‘controlled’. In meeting these requirements
non-Indigenous staff require cultural awareness training and
adequate support (especially in remote areas) [16]. Similarly,
Teasdale and colleagues (2008) identified the need for culturally
appropriate clinical services including a culturally appropriate clinic
environment, more Indigenous staff, cultural awareness training
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for non-Indigenous staff, and holistic care including partnerships
with Indigenous communities and community services [54].

Range of treatment options
The Australian Institute of Health and Welfare (2006) highlighted
the need for the provision of adequate training in alcohol and other
drug work for those staff whose skills are lacking, and importantly,
to ensure treatment encompasses a broad range of options to
minimise treatment drop-out rates reflective of restrictive and
incompatible program availability. [16]. Limited treatment options
identified by Teasdale and colleagues (2008) included a lack of
brief intervention for Indigenous youth as well as limited access to
hepatitis C assessment and treatment [54].

Despite the limited evidence for supply reduction strategies, in
2002-03, 75% of government spending in relation to illicit drugs
was spent on crime-related consequences (reactive activity)
and law enforcement-related activities (proactive activity) [10].
Similarly, Collins and Lapsley (1996) estimated that in 1992, over
80% of Commonwealth and State government expenditure in
relation to illicit drugs was allocated to law enforcement [56].
Those law enforcement strategies aimed at reducing demand among
users which showed evidence for implementation included [22]:
•

combined law enforcement and community development;
operating within a target area and combining partnership
development, law enforcement targeting drug offenders,
community policing, and community program and
infrastructure development

•

use of civil penalties to control drug and disorder problems;
typically aimed at non-offending third parties to take preventive

Cost of services
The Road to Recovery: Report on the inquiry into substance abuse in
Australian communities (2003) found that naltrexone treatment for
opioid dependent people, in contrast to alcohol dependent people,
is not available through the Pharmaceutical Benefits Scheme and,
at that time, incurred a cost of $167.00 for thirty 50mg tablets.
The Road to Recovery report also found that the shift from public
to private providers in the provision of methadone maintenance
resulted in dispensing fees charged by pharmacists ranging from
$3.50 to $7.00 per day, placing a considerable financial burden
on those individuals already experiencing significant social and
economic disadvantage [55]. Reflecting this burden of cost,
Teasdale and colleagues (2008) identified a lack of subsidised
pharmacotherapy dispensing in community pharmacies for
Indigenous clients [54].

S u pp ly r e d u c t i o n

Primary and secondary intervention
Legislative and regulatory interventions in relation to the
production, supply, possession and use of illicit substances are
supply reduction strategies and can be categorised as both a
primary and secondary prevention strategy; seeking to prevent the
uptake of use by reducing demand, and minimising existing use by
reducing supply [16].
Research by Loxley and colleagues (2004) showed limited evidence
for supply reduction strategies and highlighted the need for
much more research into those strategies in use [22]. National
data from the Australian Crime Commission (2005) show that for
2003-04 the number of arrests made in relation to drug offences
is overwhelmingly for ‘consumption’ rather than supply (80%
compared with 20%) [53]. It is unlikely that these arrests deter
use given that there are high rates of re-offending among those
convicted for illicit drug use [22].
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action to end criminal or nuisance behaviour, for example,
bans, injunctions, and restraining orders, and the fulfilment of
health and safety regulations
•

police crackdowns; designed to move drug dealers and sellers
away from a particular area

Law enforcement strategies aimed at suppliers of illicit drugs which
showed evidence for implementation was limited to [22]:
•

cannabis law reform; those policies designed to reduce
penalties for cannabis possession or use

Weatherburn (2006) makes the point that supply reduction
strategies are effective in reducing the harms of use by reducing the
level of availability, and in fact, have been requested by Indigenous
communities (as seen in dry-community initiatives). He espouses
the argument for the effectiveness and necessity of supply
reduction initiatives as highlighted by the work of Pearson, who
views alcohol and other drug addiction as so endemic that they are
now the principal cause of disadvantage rather than a symptom of
it [57]. Pearson believes the ‘gammon economy’ (dependence on
welfare and effective exclusion from the mainstream economy),
and the ensuing lack of meaning and purpose, together with
citizen rights that were equated with ‘drinking rights’, compounded
the effects of dispossession and trauma for Indigenous people,
leading to the epidemic of substance misuse and addiction
based disadvantage [58]. These views support the initiatives
of community driven supply control strategies to disrupt the
‘normalisation’ of harmful substance use.
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Policy implications
Funding

D ata

Loxley (2004) found that expenditure in Indigenous affairs over
the past three decades has failed to meet the needs of Indigenous
Australians or to remedy the social and economic inequalities that
underlie and perpetuate substance misuse among Indigenous
Australians. This inadequacy of funding includes health services
and substance misuse services and has limited the ability to build
capacity in communities and community organisations in regard
to infrastructure, research capabilities and staff development and
support [22].

The Australian Institute of Health and Welfare (2006) recognises
the need to improve the gaps in the information needed to
discern the nature of substance use problems, the contextual
factors underlying the prevalence and patterns of substance use,
and the effectiveness of interventions. Planning, implementation,
monitoring and evaluation of interventions cannot be considered
truly reflective of, and responsive to, substance use and the
harms associated with that use until data collection improves
[16]. The most fundamental data gaps that need to be addressed
are those which enable substance use and Indigenous status to
be consistently recorded and therefore allow basic prevalence
estimates across locations and population groups – such limitations
reduce the usefulness of available information on, for example,
contextual factors, information relating to patterns of substance
use, and access to services [16].

The inadequacy of funding in substance misuse prevention and
treatment services is, in part, a reflection of the national imbalance
in expenditure in favour of law-enforcement. As cited previously,
in 2002-03, government expenditure in relation to prevention,
treatment and harm reduction accounted for only 10%, 7%, and
1% respectively of total spending in relation to illicit drugs, and in
terms of proactive spending (the direct actions of government in
relation to drug policy), prevention, treatment and harm reduction
accounted for only 23%, 17%, and 3% respectively [10].
The disproportionate expenditure in relation to law-enforcement
remains despite the Ministerial Council on Drug Strategy (2001)
endorsing the statement that ‘treatment is one of the most
effective strategies for preventing drug use, crime and the next
generation of problems’ [59]. The cost effectiveness of addressing
drug problems through treatment is supported by research
from the United States which found that for every $1 invested
in addiction treatment programs, a return in excess of $12 in the
reduction of crime, criminal justice costs and health care savings
could be made [60].
The views of Weatherburn and Pearson as to the efficacy of supply
reduction (cited above) do not undermine the need for funding
in prevention and treatment at least commensurate with that of
law enforcement, but rather underline it (especially in relation to
engagement with the ‘real economy’). Strategies to address drugrelated harms must necessarily address both the causes and the
symptoms or risk the complexity of the symptoms (drug use and
drug-related harms) overshadowing the causes.
Funding which is insufficient and unbalanced undermines all of the
key result areas of the National Drug Strategy Aboriginal and Torres
Strait Islander Peoples’ Complementary Action Plan 2003-2009.
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Holism
Loxley and colleagues (2004) have shown that the recognised link
between underlying social factors and substance use has failed
to result in a coordinated and holistic approach incorporating
substance misuse policy and policies in other portfolio areas such
as education, housing and employment. Further, Indigenous
community-controlled organisations, all levels of government, and
all sectors need to be involved in substance misuse interventions.
The utility of Indigenous involvement in substance misuse
interventions is highlighted in community action frameworks
which emphasise local coalition empowerment and evidencebased investment cognisant of local evidence of elevated risk
factors and depressed protective factors [22].

P r i m a r y h e a lt h c a r e s e r v i c e s
Demand and harm reduction strategies employed across the health
sector to address substance misuse and substance misuse-related
problems require a range of generalist and specialist agencies.
Gray and colleagues (2004) highlight the potential role of primary
health care providers in the provision of comprehensive substance
misuse interventions - primary, secondary and tertiary, and as the
centre of a network of agencies; able to take referrals from, and to
provide referrals to, other treatment or support services. The key
to successful primary health care provision of substance misuse
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intervention is the availability of staff that have clearly defined
substance misuse intervention roles (with adequate staff numbers
for rotation and relief to prevent ‘burnout’), adequate training, and
programs that reflect both the social determinants of substance
misuse and the particular needs of the communities in which they
will be implemented [47].

W o r k f o r c e d e v e l o pm e n t
In 2002, funding provided for workforce development in substance
misuse specific intervention projects was less than 3% [2].
Single and Rohl (1997), in their evaluation of the National Drug
Strategy 1993-1997, recognised that a significant investment in
workforce development was essential in improving outcomes in
response to drug problems and recommended that training of
mainstream health, law enforcement and community officials was
required to effectively minimise drug-related harm, and that new
developments in prevention, treatment and research needed to be
more readily available to health care practitioners, law enforcement
officers and the public at large [61].
Research findings highlight the necessity of comprehensive training
for those people working in the field of substance misuse treatment.
Intervention strategies for those with a substance misuse problem
need to be cognisant of the stage of change that an individual is
at in order to achieve successful behaviour change [62]. The most
frequently used substance use treatment approach reported by
DASR was abstinence, which highlights a likely mismatch between
program provision and the client’s stage of change. Similarly, the
IDDI (cited above) offers assessment, education and treatment
to offenders diverted through police and court programs. The
outcome of these programs (apart from completion rates) has not
been evaluated but it is likely that interventions that do not match
an individual’s stage of change are unlikely to be successful.

Demand reduction

Social determinants of health
Research shows that those who have ‘a stake in life’ are more likely
to succeed in addressing their substance misuse and highlights
the fundamental significance of the social determinants of health
[63]. A ‘stake in conventional life’ underpins successful ‘untreated’
behaviour change (natural recovery); those with the most resources
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and the most to lose from substance misuse are those most likely
to terminate their problematic drug use without treatment.
Conversely, those who experience a sense of hopelessness are
least able to alter their drug taking behaviour. Social policy which
attempts to increase a person’s stake in conventional life can serve
to prevent future substance misuse as well as provide an anchor for
those who become dependent.

The need for a structured approach
A widespread and structured approach to primary prevention
at the individual and community level is likely to have the most
significant effect on preventing substance use and misuse; to date
such a structured approach does not exist for substance use [47].
At the individual level there is no systematic approach in primary
health care settings to follow up substance use apart from the use
of the ‘Ferret’ program in most ACCHSs which deals with tobacco
and alcohol as part of a person’s health check [47]. The need for a
culturally appropriate alcohol and other drugs and mental health
screening tool to encourage the early identification of Indigenous
people at risk has been highlighted by several government
reports [64]. The Indigenous Risk Impact Screen (IRIS) is a 13 item
screening instrument for ‘alcohol and other drugs and mental
health risk’ developed in response to this need. Schlesinger and
colleagues (2007) validated IRIS as a brief screening instrument
and recommended its use in general health-care settings because
it is easily implemented, delivered quickly, is easily comprehended
by clients and provides early identification of alcohol and other
drug misuse, mental health risks, and enables a timely response
to client needs [64]. The realisation of the potential of primary
health care services to provide comprehensive substance misuse
interventions (highlighted by Gray and colleagues (2004)) would
facilitate a seamless and timely response to those individuals
screened ‘at risk’.
At the community level projects tend to be small in scale with
limited one-off funding [47]. This is highlighted by data from 19992000, which showed that preventive programs made up only 21%
of all intervention projects targeting Indigenous people. These
programs received less than 10% of the allocated funding with
almost half receiving only short-term, non-recurrent funding.
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Summary
Secondary and tertiary intervention
The potential of primary health care services to provide
comprehensive substance misuse interventions requires the
availability of adequately trained staff with clearly defined roles
in substance misuse intervention [47]. The potential capacity of
primary health care services to provide ‘brief intervention’ for
substance misuse is limited by the fact that other than acute care
for injury and illness related to substance use, there are insufficient
resources to provide intervention services.

Ha r m r e du c t ion
Currently harm reduction services, such as clean needle exchanges,
are generally not integrated with other substance misuse services.
Gray and colleagues (2004) note the potential for primary health care
providers to provide a central networking role for substance misuse
services, able to take referrals from those involved in services such as
clean needle exchanges and other harm reduction strategies, and to
provide referrals to other treatment or support services.

S u pp ly c o n t r o l
The Royal Australasian College of Physicians (RACP) recommends
that illicit substances be redefined as primarily a health and social
issue with funding commensurate with that of law enforcement.
Citing research by Loxley and colleagues (2004) of the lack of
evidence supporting supply reduction law enforcement strategies,
the RACP recommends that supply control strategies undergo a
comprehensive economic evaluation to determine their efficacy
and to determine the nature and extent of any unintended
negative consequences [56]. Similarly, the Northern Territory’s
Select Committee on Substance Abuse in the Community (2007)
found that there was an over-reliance on supply reduction and
recommended that demand reduction and rehabilitation is
supported while ensuring supply reduction strategies anticipate
and prevent drug substitution [40].
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The use of illicit drugs among the Indigenous population is
more than twice that of the non-Indigenous population; the
trend shows illicit drug use increasing for all drug types. In
remote areas the use of cannabis among Indigenous people
is significantly greater than that of their urban counterparts.
The greater and increasing use of illicit drugs among the
Indigenous population corresponds with greater and
increasing health, social and economic impacts compared
with the non-Indigenous population. The health impacts of
illicit drug use include increases in morbidity for accidental
poisoning involving illicit drugs, significant increases
in HIV/AIDS and hepatitis C rates, higher rates of drugrelated mental/behavioural disorders, and the likelihood
of significant rates of comorbidity and increases in suicide
ideation and completion. Familial and community impacts
include stressful family relationships, violence, harm to
children and increases in crime and incarceration as well
as significant economic costs borne by the individual, the
family and the community.
Like the misuse of licit drugs among Indigenous people, the
misuse of illicit drugs must be viewed against the backdrop
of dispossession and oppression and the continuing legacy
of exclusion and marginalisation of Indigenous people in
Australia. This context explains the grave disparities in the
social determinants of health that exist today for Indigenous
people compared with non-Indigenous people. Indigenous
people are significantly less likely to be educated, to be
employed, to earn a level of income above subsistence
and to live in adequate housing than their non-Indigenous
counterparts. Such disadvantage fuels the stressors of
life and perpetuates the dysfunction of families and
communities; creating the conditions in which solace in
drugs is sought.
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The National Drug Strategy and the National Drug Strategy
Aboriginal and Torres Strait Islander Peoples’Complementary
Action Plan 2003-2009 seek to address illicit drug misuse
among Indigenous people through harm minimisation;
policies of demand reduction, harm reduction and supply
reduction seek to improve the health, social, and economic
outcomes for both the individual and the community.
The key result areas consist of enhancing the capacity of
Indigenous people to be involved in the promotion of their
own wellbeing, whole-of-government responses to the
reduction of drug-related harms, accessibility of services,
holistic approaches, workforce initiatives, and sustainable
partnerships between all stakeholders inclusive of
Indigenous communities in research, monitoring, evaluation
and dissemination of information.
The enhancement of the capacity of Indigenous people to
be involved in the promotion of their own wellbeing requires
significant improvements in education and employment,
but the need to address these underlying social factors
has not resulted in a coordinated and holistic approach
to substance misuse policy and therefore limits several
of the key result areas. Similarly, the services available to
Indigenous people show a lack of primary interventions for
demand reduction, with a reliance on treatment rather than
prevention. The unproven over-reliance on supply control
strategies and the associated focus on law rather than health
are not reflective of a whole-of-government and holistic
response to the reduction of drug-related harms and may in
fact add to the burden of harm for the user. Fundamental to
all of the key result areas is an appropriate level of funding
commensurate with need; underfunding and the nature of
short-term non-recurrent funding undermines the ability
to make tangible and lasting improvements in Indigenous
health status including illicit drug misuse and its impacts.
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Effective prevention and treatment (ensuring that we are not
dealing with an endless flow of symptoms) rests primarily
with equity in the social determinants of health. Evidence
shows us the pervasive role disadvantage plays in the stark
disparities in health status experienced by Indigenous
people compared with non-Indigenous people; illicit drug
misuse is intrinsically a part of this picture – it is perpetrated
by disadvantage, thrives in disadvantage and compounds
disadvantage.
The challenge for governments to address the social inequity
experienced by Indigenous people remains. The change of
government in November 2007 has brought the opportunity
for a new beginning in Indigenous affairs. The ‘Sorry Day’
speech of the Rudd Government on 13 February 2008, formally
acknowledging and expressing sorrow for the wrongs of past
policies in relation to the ‘Stolen Generations’, is an important
first step of healing for Indigenous people and gives us reason
as a nation to hope that the will of government is now such
that ‘closing the gap’ is more than rhetoric.
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Appendix 1
E xt e n t of i l l ic i t dru g u se i n
Au s t r a l ia
According to the 2007 National Drug Strategy Household Survey
First Results (NDSHS) 1 [12]
•

38% of Australians aged 14 years or older (more than 6 million
people) had used an illicit drug at least once in their lifetime;
13% (more than 2 million people) had used an illicit drug at
least once in the previous 12 months

•

cannabis was the most common illicit drug used – 33% of the
population had ever used the drug and 9% had used in the
previous year

•

recent use of illicit drugs was most common among people
aged 20-29 years of age (with almost one-third of males and
one quarter of females using an illicit drug in the previous
year), and for those aged 14–19 years (with around one-sixth
of both males and females using an illicit drug in the previous
year)According to the 2004 National Drug Strategy Household
Survey 2 (detailed results of the 2007 NDSHS were not
available at the time of writing) [41] the highest proportion of
recent drug use was for people who were unemployed – more
than one-third (32%) had used an illicit drug recently, more
than twice the level for the total population (15%).

•

recent illicit drug use was more common among the most
socioeconomically disadvantaged (17%) than among people
in other socioeconomic groups

•

illicit drug use in the previous 12 months was more common
for people living in remote and very remote regions (19%) than
for those living in other regions

•

for illicit drugs other than cannabis, use in the previous 12
months was highest for people living in major cities (9%)

1

The NDSHS is conducted every three years. In 2007 the sample
size was 23,356 persons aged 12 years and over. The analysis
presented in almost all of the report relates to Australians aged
14 years and older. 12 Australian Institute of Health and Welfare
(2008) National drug strategy household survey: 2007 first
results. (AIHW Catalogue no. PHE 98) Canberra: Australian
Institute of Health and Welfare.

2

In 2004 the sample size was 29,445 persons aged 12 years and
over. The analysis presented in almost all of the report relates to
Australians aged 14 years and older. 41 Australian Institute of
Health and Welfare (2005) 2004 National Drug Strategy Household

Appendix 2
S o u r c e s a n d l i m i tat i o n s o f
i n f o r m at i o n o n i l l i c i t d r u g u s e
among Indigenous people
The three main sources of information about illicit drug use among
Indigenous people are population surveys; the 2002 National
Aboriginal and Torres Strait Islander Social Survey (NATSISS), the
2004–2005 National Aboriginal and Torres Strait Islander Health
Survey (NATSIHS) and the 2004 AND 2007 National Drug Strategy
Household Surveys (NDSHS).

2002 NATSISS
The 2002 NATSISS, a household survey conducted by the ABS,
collected information from 9,400 Indigenous people aged 15 years
or older [14]. Respondents lived in private dwellings and came
from all states and territories. The ABS plans to conduct the survey
every six years.
Limitations of this survey include:
•

the lack of confidentiality in gathering information, resulting
in a tendency for individuals to underestimate substance use
(the unreliable nature of the illicit drug use data for people
living in remote areas prevented its inclusion altogether) [65]

•

it did not include people living in non-private dwellings
(according to the 2001 census, 4% of the Indigenous
population resides in non-private dwellings [13]) [65]

Given the exclusion of people living in remote areas (in 2001,
around one-quarter of the Indigenous population [13]) and
those living in non-private dwellings (likely to be the most
socioeconomically disadvantaged group with the associated
higher risks for substance use), the underestimation of illicit drug
use among Indigenous people is likely to be significant [65].

Survey: detailed findings. (AIHW catalogue no. PHE 66) Canberra:
Australian Institute of Health and Welfare.
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2004-2005 NATSIHS
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2004 NDSHS
The 2004 NDSHS, conducted by the AIHW, collected drug use
information from 29,445 people aged 12 years or 14 years or older
(as specified) residing in private households. Information on illicit
drug use was presented for people aged 14 years or older. Only 463
Indigenous respondents were included in this survey and therefore
estimates must be interpreted with caution [11, 41].

2007 NDSHS: First results
The 2007 NDSHS, conducted by the AIHW, collected drug use
information from 23,356 people aged 12 years or older or 14 years
or older (as specified) residing in private households [12]. The
analysis presented in almost all of the report relates to Australians
aged 14 years and older. The 2007 NDSHS first results do not include
information on the number of Indigenous respondents. Detailed
findings were not available at the time of writing.

Evidence from other sources
As well as these population surveys, some information about illicit
drug use among Indigenous people is available from a number of
relatively small-scale studies and special reviews. Examples are the
studies of cannabis use among Indigenous people living in remote
communities in Arnhem Land [17], and the reviews undertaken
by the Australasian Centre for Policing Research [18] and the
Australian Institute of Criminology [19].
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